204 related articles for article (PubMed ID: 30355937)
1. Clinicopathological Aspects of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: a Multicenter Retrospective Study and Meta-Analysis.
Xu F; Ma J; Yi H; Hu H; Fan L; Wu P; Chen X; Wu X; Yu L; Xing H; Wang W
Cell Physiol Biochem; 2018; 50(3):1113-1122. PubMed ID: 30355937
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
5. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
7. Small cell carcinoma of the uterine cervix: a multi-institutional experience.
Li J; Ouyang Y; Tao Y; Wang L; Li M; Gao L; Cao X
Int J Gynecol Cancer; 2020 Feb; 30(2):174-180. PubMed ID: 31792086
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
[TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
10. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
11. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
12. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
14. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
[TBL] [Abstract][Full Text] [Related]
15. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
Zhang Y; Ding J; Hua K
J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
[TBL] [Abstract][Full Text] [Related]
16. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
Zhang X; Lv Z; Lou H
BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
[TBL] [Abstract][Full Text] [Related]
19. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study.
Kim HS; Choi CH; Lim MC; Chang SJ; Kim YB; Kim MA; Kim TJ; Park SY; Kim BG; Song YS; Bae DS; Kim JW
Ann Surg Oncol; 2012 Jun; 19(6):1973-9. PubMed ID: 22183162
[TBL] [Abstract][Full Text] [Related]
20. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]